nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—CYP2C18—prostate cancer	0.0931	0.312	CbGaD
Verapamil—SLC22A1—prostate cancer	0.076	0.254	CbGaD
Verapamil—CYP3A5—prostate cancer	0.0614	0.205	CbGaD
Verapamil—CYP2C19—prostate cancer	0.0418	0.14	CbGaD
Verapamil—CYP3A4—prostate cancer	0.0266	0.0889	CbGaD
Verapamil—ABCC10—Estradiol—prostate cancer	0.0178	0.039	CbGbCtD
Verapamil—ABCC1—Abiraterone—prostate cancer	0.0166	0.0362	CbGbCtD
Verapamil—ABCB11—Ethinyl Estradiol—prostate cancer	0.015	0.0329	CbGbCtD
Verapamil—ABCC3—Conjugated Estrogens—prostate cancer	0.0128	0.0279	CbGbCtD
Verapamil—ABCC10—Etoposide—prostate cancer	0.0116	0.0254	CbGbCtD
Verapamil—SLCO1A2—Estrone—prostate cancer	0.0107	0.0234	CbGbCtD
Verapamil—ABCC10—Docetaxel—prostate cancer	0.0106	0.0233	CbGbCtD
Verapamil—SLCO1B1—Cabazitaxel—prostate cancer	0.0103	0.0226	CbGbCtD
Verapamil—SLCO1B1—Estrone—prostate cancer	0.0101	0.0221	CbGbCtD
Verapamil—ABCC4—Conjugated Estrogens—prostate cancer	0.00975	0.0213	CbGbCtD
Verapamil—ABCG2—Cabazitaxel—prostate cancer	0.0082	0.0179	CbGbCtD
Verapamil—ABCG2—Estrone—prostate cancer	0.00802	0.0175	CbGbCtD
Verapamil—ABCC10—Doxorubicin—prostate cancer	0.00794	0.0173	CbGbCtD
Verapamil—ABCC2—Ethinyl Estradiol—prostate cancer	0.0079	0.0173	CbGbCtD
Verapamil—ABCC1—Conjugated Estrogens—prostate cancer	0.00784	0.0171	CbGbCtD
Verapamil—ABCC3—Etoposide—prostate cancer	0.00732	0.016	CbGbCtD
Verapamil—CYP2C8—Nilutamide—prostate cancer	0.00713	0.0156	CbGbCtD
Verapamil—ABCC1—Mitoxantrone—prostate cancer	0.00712	0.0156	CbGbCtD
Verapamil—SLCO1A2—Conjugated Estrogens—prostate cancer	0.007	0.0153	CbGbCtD
Verapamil—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0066	0.0144	CbGbCtD
Verapamil—SLCO1A2—Estradiol—prostate cancer	0.00614	0.0134	CbGbCtD
Verapamil—CYP3A5—Flutamide—prostate cancer	0.00614	0.0134	CbGbCtD
Verapamil—CYP2C19—Nilutamide—prostate cancer	0.00598	0.0131	CbGbCtD
Verapamil—CYP2C19—Bicalutamide—prostate cancer	0.00598	0.0131	CbGbCtD
Verapamil—CYP2C8—Abiraterone—prostate cancer	0.00591	0.0129	CbGbCtD
Verapamil—ABCC2—Conjugated Estrogens—prostate cancer	0.0058	0.0127	CbGbCtD
Verapamil—SLCO1B1—Estradiol—prostate cancer	0.0058	0.0127	CbGbCtD
Verapamil—ABCC1—Epirubicin—prostate cancer	0.00577	0.0126	CbGbCtD
Verapamil—CYP2B6—Estrone—prostate cancer	0.00564	0.0123	CbGbCtD
Verapamil—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0055	0.012	CbGbCtD
Verapamil—SLC22A1—Estradiol—prostate cancer	0.00542	0.0118	CbGbCtD
Verapamil—SLCO1A2—Prednisone—prostate cancer	0.00528	0.0115	CbGbCtD
Verapamil—ABCG2—Conjugated Estrogens—prostate cancer	0.00524	0.0115	CbGbCtD
Verapamil—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00503	0.011	CbGbCtD
Verapamil—ABCC3—Doxorubicin—prostate cancer	0.00499	0.0109	CbGbCtD
Verapamil—CYP2C9—Nilutamide—prostate cancer	0.00497	0.0109	CbGbCtD
Verapamil—CYP2C9—Bicalutamide—prostate cancer	0.00497	0.0109	CbGbCtD
Verapamil—CYP2C19—Flutamide—prostate cancer	0.00496	0.0108	CbGbCtD
Verapamil—ABCG2—Mitoxantrone—prostate cancer	0.00477	0.0104	CbGbCtD
Verapamil—ABCG2—Estradiol—prostate cancer	0.0046	0.0101	CbGbCtD
Verapamil—CYP1A2—Flutamide—prostate cancer	0.00457	0.00999	CbGbCtD
Verapamil—CYP2D6—Bicalutamide—prostate cancer	0.00455	0.00994	CbGbCtD
Verapamil—CYP3A5—Cabazitaxel—prostate cancer	0.00454	0.00993	CbGbCtD
Verapamil—ABCC1—Etoposide—prostate cancer	0.00449	0.00982	CbGbCtD
Verapamil—ABCB1—Estramustine—prostate cancer	0.00449	0.0098	CbGbCtD
Verapamil—CYP3A5—Estrone—prostate cancer	0.00444	0.00971	CbGbCtD
Verapamil—CYP2C8—Cabazitaxel—prostate cancer	0.00437	0.00955	CbGbCtD
Verapamil—ABCB11—Doxorubicin—prostate cancer	0.00431	0.00943	CbGbCtD
Verapamil—ABCC1—Docetaxel—prostate cancer	0.00411	0.00898	CbGbCtD
Verapamil—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00381	0.00832	CbGbCtD
Verapamil—CYP2D6—Abiraterone—prostate cancer	0.00377	0.00823	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0034	0.00743	CbGbCtD
Verapamil—CYP3A7—Estradiol—prostate cancer	0.0034	0.00743	CbGbCtD
Verapamil—ABCC2—Etoposide—prostate cancer	0.00333	0.00727	CbGbCtD
Verapamil—CYP1A2—Estrone—prostate cancer	0.00331	0.00723	CbGbCtD
Verapamil—ABCC1—Doxorubicin—prostate cancer	0.00306	0.0067	CbGbCtD
Verapamil—ABCC2—Docetaxel—prostate cancer	0.00304	0.00665	CbGbCtD
Verapamil—ABCG2—Etoposide—prostate cancer	0.00301	0.00657	CbGbCtD
Verapamil—CYP2C9—Estrone—prostate cancer	0.00298	0.00651	CbGbCtD
Verapamil—ABCB1—Cabazitaxel—prostate cancer	0.00296	0.00646	CbGbCtD
Verapamil—CYP3A4—Bicalutamide—prostate cancer	0.00289	0.00632	CbGbCtD
Verapamil—ABCB1—Estrone—prostate cancer	0.00289	0.00632	CbGbCtD
Verapamil—ABCG2—Docetaxel—prostate cancer	0.00275	0.00601	CbGbCtD
Verapamil—CYP3A4—Estramustine—prostate cancer	0.00269	0.00587	CbGbCtD
Verapamil—ABCB1—Ethinyl Estradiol—prostate cancer	0.00258	0.00563	CbGbCtD
Verapamil—CYP3A5—Estradiol—prostate cancer	0.00255	0.00558	CbGbCtD
Verapamil—CYP2C8—Estradiol—prostate cancer	0.00245	0.00536	CbGbCtD
Verapamil—CYP3A4—Abiraterone—prostate cancer	0.0024	0.00524	CbGbCtD
Verapamil—CYP3A4—Flutamide—prostate cancer	0.0024	0.00524	CbGbCtD
Verapamil—ABCC2—Doxorubicin—prostate cancer	0.00227	0.00496	CbGbCtD
Verapamil—CYP2C9—Capecitabine—prostate cancer	0.00226	0.00493	CbGbCtD
Verapamil—CYP1A2—Conjugated Estrogens—prostate cancer	0.00216	0.00473	CbGbCtD
Verapamil—CYP2C19—Estradiol—prostate cancer	0.00206	0.0045	CbGbCtD
Verapamil—ABCG2—Doxorubicin—prostate cancer	0.00205	0.00448	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00203	0.00444	CbGbCtD
Verapamil—CYP3A7—Docetaxel—prostate cancer	0.00203	0.00444	CbGbCtD
Verapamil—CYP1A2—Estradiol—prostate cancer	0.0019	0.00415	CbGbCtD
Verapamil—ABCB1—Conjugated Estrogens—prostate cancer	0.00189	0.00413	CbGbCtD
Verapamil—CYP3A4—Cabazitaxel—prostate cancer	0.00177	0.00387	CbGbCtD
Verapamil—CYP2C19—Prednisone—prostate cancer	0.00177	0.00387	CbGbCtD
Verapamil—CYP3A4—Estrone—prostate cancer	0.00173	0.00379	CbGbCtD
Verapamil—ABCB1—Mitoxantrone—prostate cancer	0.00172	0.00376	CbGbCtD
Verapamil—CYP2C9—Estradiol—prostate cancer	0.00171	0.00374	CbGbCtD
Verapamil—CYP3A5—Etoposide—prostate cancer	0.00167	0.00364	CbGbCtD
Verapamil—ABCB1—Estradiol—prostate cancer	0.00166	0.00363	CbGbCtD
Verapamil—CYP2C8—Etoposide—prostate cancer	0.0016	0.0035	CbGbCtD
Verapamil—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00154	0.00337	CbGbCtD
Verapamil—CYP3A5—Docetaxel—prostate cancer	0.00152	0.00333	CbGbCtD
Verapamil—CACNB4—prostate gland—prostate cancer	0.00145	0.0371	CbGeAlD
Verapamil—CYP2B6—Doxorubicin—prostate cancer	0.00144	0.00315	CbGbCtD
Verapamil—ABCB1—Prednisone—prostate cancer	0.00143	0.00312	CbGbCtD
Verapamil—CYP1A2—Etoposide—prostate cancer	0.00124	0.00271	CbGbCtD
Verapamil—CACNB1—prostate gland—prostate cancer	0.00115	0.0296	CbGeAlD
Verapamil—CYP3A4—Conjugated Estrogens—prostate cancer	0.00113	0.00248	CbGbCtD
Verapamil—CACNB3—prostate gland—prostate cancer	0.00111	0.0284	CbGeAlD
Verapamil—ABCB1—Etoposide—prostate cancer	0.00108	0.00237	CbGbCtD
Verapamil—CACNA1S—seminal vesicle—prostate cancer	0.00105	0.0269	CbGeAlD
Verapamil—CYP2C19—urine—prostate cancer	0.00104	0.0268	CbGeAlD
Verapamil—CYP3A4—Mitoxantrone—prostate cancer	0.00103	0.00225	CbGbCtD
Verapamil—CYP3A4—Estradiol—prostate cancer	0.000995	0.00217	CbGbCtD
Verapamil—ABCB1—Docetaxel—prostate cancer	0.000992	0.00217	CbGbCtD
Verapamil—CACNB3—seminal vesicle—prostate cancer	0.000937	0.024	CbGeAlD
Verapamil—CYP3A4—Prednisone—prostate cancer	0.000855	0.00187	CbGbCtD
Verapamil—CYP1A2—urine—prostate cancer	0.000853	0.0219	CbGeAlD
Verapamil—CYP2C9—urine—prostate cancer	0.00081	0.0208	CbGeAlD
Verapamil—CACNA1H—prostate gland—prostate cancer	0.000788	0.0202	CbGeAlD
Verapamil—CACNA1I—testis—prostate cancer	0.000774	0.0198	CbGeAlD
Verapamil—CACNB2—prostate gland—prostate cancer	0.000744	0.0191	CbGeAlD
Verapamil—CACNB3—urethra—prostate cancer	0.000741	0.019	CbGeAlD
Verapamil—ABCB1—Doxorubicin—prostate cancer	0.000739	0.00162	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—prostate cancer	0.000697	0.00152	CbGbCtD
Verapamil—CACNA1H—seminal vesicle—prostate cancer	0.000666	0.0171	CbGeAlD
Verapamil—CACNA1D—prostate gland—prostate cancer	0.00065	0.0167	CbGeAlD
Verapamil—CYP3A4—Etoposide—prostate cancer	0.00065	0.00142	CbGbCtD
Verapamil—CACNB4—testis—prostate cancer	0.000637	0.0163	CbGeAlD
Verapamil—CYP3A4—urine—prostate cancer	0.000618	0.0158	CbGeAlD
Verapamil—CACNA1A—testis—prostate cancer	0.000608	0.0156	CbGeAlD
Verapamil—CYP2D6—urine—prostate cancer	0.000608	0.0156	CbGeAlD
Verapamil—CACNA1C—prostate gland—prostate cancer	0.0006	0.0154	CbGeAlD
Verapamil—CYP3A4—Docetaxel—prostate cancer	0.000594	0.0013	CbGbCtD
Verapamil—CACNA1B—testis—prostate cancer	0.000593	0.0152	CbGeAlD
Verapamil—CACNA1I—lymph node—prostate cancer	0.000561	0.0144	CbGeAlD
Verapamil—ABCC3—prostate gland—prostate cancer	0.000546	0.014	CbGeAlD
Verapamil—ABCC10—prostate gland—prostate cancer	0.000543	0.0139	CbGeAlD
Verapamil—SLC22A4—prostate gland—prostate cancer	0.000511	0.0131	CbGeAlD
Verapamil—CACNB1—testis—prostate cancer	0.000509	0.013	CbGeAlD
Verapamil—CACNB3—testis—prostate cancer	0.000488	0.0125	CbGeAlD
Verapamil—ABCC10—seminal vesicle—prostate cancer	0.00046	0.0118	CbGeAlD
Verapamil—ABCC4—prostate gland—prostate cancer	0.000451	0.0116	CbGeAlD
Verapamil—CYP3A4—Doxorubicin—prostate cancer	0.000443	0.000968	CbGbCtD
Verapamil—ABCC2—prostate gland—prostate cancer	0.000436	0.0112	CbGeAlD
Verapamil—SLC22A4—seminal vesicle—prostate cancer	0.000432	0.0111	CbGeAlD
Verapamil—CACNA1B—lymph node—prostate cancer	0.00043	0.011	CbGeAlD
Verapamil—SLCO1B1—renal system—prostate cancer	0.000392	0.0101	CbGeAlD
Verapamil—ABCC1—prostate gland—prostate cancer	0.000384	0.00986	CbGeAlD
Verapamil—ABCB11—testis—prostate cancer	0.000378	0.00969	CbGeAlD
Verapamil—ABCC3—renal system—prostate cancer	0.000372	0.00954	CbGeAlD
Verapamil—ABCC10—renal system—prostate cancer	0.00037	0.0095	CbGeAlD
Verapamil—CACNB1—lymph node—prostate cancer	0.000369	0.00945	CbGeAlD
Verapamil—ABCC10—urethra—prostate cancer	0.000364	0.00933	CbGeAlD
Verapamil—KCNH2—prostate gland—prostate cancer	0.000358	0.00917	CbGeAlD
Verapamil—CACNB3—lymph node—prostate cancer	0.000354	0.00907	CbGeAlD
Verapamil—SLC22A4—renal system—prostate cancer	0.000348	0.00893	CbGeAlD
Verapamil—CACNA1H—testis—prostate cancer	0.000347	0.0089	CbGeAlD
Verapamil—SLC22A5—prostate gland—prostate cancer	0.000338	0.00867	CbGeAlD
Verapamil—SLC22A1—renal system—prostate cancer	0.000332	0.0085	CbGeAlD
Verapamil—CACNB2—testis—prostate cancer	0.000328	0.0084	CbGeAlD
Verapamil—ABCC1—seminal vesicle—prostate cancer	0.000325	0.00834	CbGeAlD
Verapamil—SLCO1A2—renal system—prostate cancer	0.000319	0.00819	CbGeAlD
Verapamil—ABCG2—prostate gland—prostate cancer	0.000318	0.00816	CbGeAlD
Verapamil—ABCC4—renal system—prostate cancer	0.000307	0.00788	CbGeAlD
Verapamil—KCNH2—seminal vesicle—prostate cancer	0.000303	0.00776	CbGeAlD
Verapamil—Bevantolol—ADRB2—prostate cancer	0.000302	0.571	CrCbGaD
Verapamil—ABCC2—renal system—prostate cancer	0.000297	0.00763	CbGeAlD
Verapamil—CYP3A5—prostate gland—prostate cancer	0.000295	0.00757	CbGeAlD
Verapamil—CACNA1D—testis—prostate cancer	0.000286	0.00735	CbGeAlD
Verapamil—SLC22A5—seminal vesicle—prostate cancer	0.000286	0.00733	CbGeAlD
Verapamil—ABCC10—bone marrow—prostate cancer	0.00028	0.00718	CbGeAlD
Verapamil—ABCG2—seminal vesicle—prostate cancer	0.000269	0.0069	CbGeAlD
Verapamil—CACNA1C—testis—prostate cancer	0.000264	0.00678	CbGeAlD
Verapamil—SLC22A4—bone marrow—prostate cancer	0.000263	0.00675	CbGeAlD
Verapamil—ABCC1—urethra—prostate cancer	0.000257	0.0066	CbGeAlD
Verapamil—CACNA1H—lymph node—prostate cancer	0.000252	0.00645	CbGeAlD
Verapamil—KCNH2—renal system—prostate cancer	0.000244	0.00625	CbGeAlD
Verapamil—ABCC3—testis—prostate cancer	0.000241	0.00617	CbGeAlD
Verapamil—KCNH2—urethra—prostate cancer	0.000239	0.00614	CbGeAlD
Verapamil—ABCC10—testis—prostate cancer	0.000239	0.00614	CbGeAlD
Verapamil—CACNB2—lymph node—prostate cancer	0.000238	0.00609	CbGeAlD
Verapamil—ABCC4—bone marrow—prostate cancer	0.000232	0.00596	CbGeAlD
Verapamil—SLC22A5—renal system—prostate cancer	0.00023	0.00591	CbGeAlD
Verapamil—Tofisopam—CYP3A4—prostate cancer	0.000227	0.429	CrCbGaD
Verapamil—SLC22A5—urethra—prostate cancer	0.000226	0.0058	CbGeAlD
Verapamil—KCNJ11—lymph node—prostate cancer	0.000225	0.00578	CbGeAlD
Verapamil—CYP2C8—renal system—prostate cancer	0.000223	0.00572	CbGeAlD
Verapamil—ABCG2—urethra—prostate cancer	0.000213	0.00546	CbGeAlD
Verapamil—CYP1A2—renal system—prostate cancer	0.000209	0.00535	CbGeAlD
Verapamil—CACNA1D—lymph node—prostate cancer	0.000208	0.00532	CbGeAlD
Verapamil—SLCO1A2—testis—prostate cancer	0.000206	0.00529	CbGeAlD
Verapamil—CYP3A5—renal system—prostate cancer	0.000201	0.00516	CbGeAlD
Verapamil—CYP2B6—renal system—prostate cancer	0.0002	0.00513	CbGeAlD
Verapamil—ABCC4—testis—prostate cancer	0.000199	0.00509	CbGeAlD
Verapamil—ABCC2—testis—prostate cancer	0.000192	0.00493	CbGeAlD
Verapamil—CACNA1C—lymph node—prostate cancer	0.000192	0.00492	CbGeAlD
Verapamil—KCNH2—bone marrow—prostate cancer	0.000184	0.00473	CbGeAlD
Verapamil—ABCC3—lymph node—prostate cancer	0.000174	0.00447	CbGeAlD
Verapamil—ABCC10—lymph node—prostate cancer	0.000174	0.00445	CbGeAlD
Verapamil—ABCC1—testis—prostate cancer	0.000169	0.00434	CbGeAlD
Verapamil—ABCG2—bone marrow—prostate cancer	0.000164	0.0042	CbGeAlD
Verapamil—SLC22A4—lymph node—prostate cancer	0.000163	0.00418	CbGeAlD
Verapamil—KCNH2—testis—prostate cancer	0.000158	0.00404	CbGeAlD
Verapamil—ABCB1—prostate gland—prostate cancer	0.000157	0.00402	CbGeAlD
Verapamil—CYP3A4—renal system—prostate cancer	0.000151	0.00387	CbGeAlD
Verapamil—SLC22A5—testis—prostate cancer	0.000149	0.00382	CbGeAlD
Verapamil—CYP2D6—renal system—prostate cancer	0.000149	0.00381	CbGeAlD
Verapamil—CYP2C8—testis—prostate cancer	0.000144	0.0037	CbGeAlD
Verapamil—ABCC4—lymph node—prostate cancer	0.000144	0.00369	CbGeAlD
Verapamil—ABCG2—testis—prostate cancer	0.00014	0.00359	CbGeAlD
Verapamil—ABCC2—lymph node—prostate cancer	0.000139	0.00357	CbGeAlD
Verapamil—ABCB1—seminal vesicle—prostate cancer	0.000133	0.0034	CbGeAlD
Verapamil—CYP2B6—testis—prostate cancer	0.000129	0.00332	CbGeAlD
Verapamil—ABCC1—lymph node—prostate cancer	0.000123	0.00315	CbGeAlD
Verapamil—ABCB1—epithelium—prostate cancer	0.000115	0.00296	CbGeAlD
Verapamil—KCNH2—lymph node—prostate cancer	0.000114	0.00293	CbGeAlD
Verapamil—SLC22A5—lymph node—prostate cancer	0.000108	0.00277	CbGeAlD
Verapamil—ABCB1—renal system—prostate cancer	0.000107	0.00274	CbGeAlD
Verapamil—ABCB1—urethra—prostate cancer	0.000105	0.00269	CbGeAlD
Verapamil—ABCG2—lymph node—prostate cancer	0.000102	0.00261	CbGeAlD
Verapamil—CYP2D6—testis—prostate cancer	9.61e-05	0.00246	CbGeAlD
Verapamil—ABCB1—bone marrow—prostate cancer	8.09e-05	0.00207	CbGeAlD
Verapamil—ABCB1—testis—prostate cancer	6.91e-05	0.00177	CbGeAlD
Verapamil—ABCB1—lymph node—prostate cancer	5.01e-05	0.00128	CbGeAlD
Verapamil—Hypertension—Docetaxel—prostate cancer	4.37e-05	0.000436	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—prostate cancer	4.36e-05	0.000435	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—prostate cancer	4.33e-05	0.000432	CcSEcCtD
Verapamil—Palpitations—Capecitabine—prostate cancer	4.33e-05	0.000432	CcSEcCtD
Verapamil—Arthralgia—Docetaxel—prostate cancer	4.3e-05	0.000429	CcSEcCtD
Verapamil—Chest pain—Docetaxel—prostate cancer	4.3e-05	0.000429	CcSEcCtD
Verapamil—Myalgia—Docetaxel—prostate cancer	4.3e-05	0.000429	CcSEcCtD
Verapamil—Loss of consciousness—Capecitabine—prostate cancer	4.3e-05	0.000429	CcSEcCtD
Verapamil—Asthenia—Mitoxantrone—prostate cancer	4.28e-05	0.000427	CcSEcCtD
Verapamil—Fatigue—Etoposide—prostate cancer	4.28e-05	0.000427	CcSEcCtD
Verapamil—Jaundice—Epirubicin—prostate cancer	4.25e-05	0.000424	CcSEcCtD
Verapamil—Constipation—Etoposide—prostate cancer	4.25e-05	0.000424	CcSEcCtD
Verapamil—Pain—Etoposide—prostate cancer	4.25e-05	0.000424	CcSEcCtD
Verapamil—Dizziness—Estradiol—prostate cancer	4.24e-05	0.000423	CcSEcCtD
Verapamil—Hypertension—Capecitabine—prostate cancer	4.23e-05	0.000422	CcSEcCtD
Verapamil—Dry mouth—Docetaxel—prostate cancer	4.21e-05	0.00042	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.21e-05	0.00042	CcSEcCtD
Verapamil—Sweating—Epirubicin—prostate cancer	4.18e-05	0.000417	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—prostate cancer	4.18e-05	0.000417	CcSEcCtD
Verapamil—Arthralgia—Capecitabine—prostate cancer	4.17e-05	0.000416	CcSEcCtD
Verapamil—Myalgia—Capecitabine—prostate cancer	4.17e-05	0.000416	CcSEcCtD
Verapamil—Chest pain—Capecitabine—prostate cancer	4.17e-05	0.000416	CcSEcCtD
Verapamil—Confusional state—Docetaxel—prostate cancer	4.16e-05	0.000415	CcSEcCtD
Verapamil—Oedema—Docetaxel—prostate cancer	4.13e-05	0.000412	CcSEcCtD
Verapamil—Anaphylactic shock—Docetaxel—prostate cancer	4.13e-05	0.000412	CcSEcCtD
Verapamil—Discomfort—Capecitabine—prostate cancer	4.12e-05	0.000411	CcSEcCtD
Verapamil—Vision blurred—Prednisone—prostate cancer	4.11e-05	0.00041	CcSEcCtD
Verapamil—Infection—Docetaxel—prostate cancer	4.1e-05	0.000409	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—prostate cancer	4.09e-05	0.000409	CcSEcCtD
Verapamil—Feeling abnormal—Etoposide—prostate cancer	4.09e-05	0.000408	CcSEcCtD
Verapamil—Diarrhoea—Mitoxantrone—prostate cancer	4.08e-05	0.000408	CcSEcCtD
Verapamil—Dry mouth—Capecitabine—prostate cancer	4.08e-05	0.000407	CcSEcCtD
Verapamil—Vomiting—Estradiol—prostate cancer	4.07e-05	0.000406	CcSEcCtD
Verapamil—Shock—Docetaxel—prostate cancer	4.06e-05	0.000405	CcSEcCtD
Verapamil—Rash—Estradiol—prostate cancer	4.04e-05	0.000403	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—prostate cancer	4.04e-05	0.000403	CcSEcCtD
Verapamil—Dermatitis—Estradiol—prostate cancer	4.04e-05	0.000403	CcSEcCtD
Verapamil—Confusional state—Capecitabine—prostate cancer	4.03e-05	0.000402	CcSEcCtD
Verapamil—Tachycardia—Docetaxel—prostate cancer	4.03e-05	0.000402	CcSEcCtD
Verapamil—Headache—Estradiol—prostate cancer	4.01e-05	0.0004	CcSEcCtD
Verapamil—Agitation—Prednisone—prostate cancer	4.01e-05	0.0004	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	4e-05	0.000399	CcSEcCtD
Verapamil—Oedema—Capecitabine—prostate cancer	4e-05	0.000399	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—prostate cancer	3.99e-05	0.000398	CcSEcCtD
Verapamil—Angioedema—Prednisone—prostate cancer	3.98e-05	0.000398	CcSEcCtD
Verapamil—Infection—Capecitabine—prostate cancer	3.97e-05	0.000396	CcSEcCtD
Verapamil—Urticaria—Etoposide—prostate cancer	3.94e-05	0.000394	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—prostate cancer	3.94e-05	0.000393	CcSEcCtD
Verapamil—Shock—Capecitabine—prostate cancer	3.93e-05	0.000392	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—prostate cancer	3.93e-05	0.000392	CcSEcCtD
Verapamil—Vertigo—Prednisone—prostate cancer	3.92e-05	0.000391	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—prostate cancer	3.92e-05	0.000391	CcSEcCtD
Verapamil—Syncope—Prednisone—prostate cancer	3.91e-05	0.00039	CcSEcCtD
Verapamil—Tachycardia—Capecitabine—prostate cancer	3.9e-05	0.000389	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—prostate cancer	3.9e-05	0.000389	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—prostate cancer	3.89e-05	0.000388	CcSEcCtD
Verapamil—Sweating—Doxorubicin—prostate cancer	3.87e-05	0.000386	CcSEcCtD
Verapamil—Hyperhidrosis—Capecitabine—prostate cancer	3.86e-05	0.000385	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—prostate cancer	3.86e-05	0.000385	CcSEcCtD
Verapamil—Hypotension—Docetaxel—prostate cancer	3.86e-05	0.000385	CcSEcCtD
Verapamil—Loss of consciousness—Prednisone—prostate cancer	3.83e-05	0.000382	CcSEcCtD
Verapamil—Nausea—Estradiol—prostate cancer	3.81e-05	0.00038	CcSEcCtD
Verapamil—Vomiting—Mitoxantrone—prostate cancer	3.8e-05	0.000379	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—prostate cancer	3.79e-05	0.000378	CcSEcCtD
Verapamil—Convulsion—Prednisone—prostate cancer	3.78e-05	0.000377	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—prostate cancer	3.78e-05	0.000377	CcSEcCtD
Verapamil—Hypertension—Prednisone—prostate cancer	3.76e-05	0.000376	CcSEcCtD
Verapamil—Rash—Mitoxantrone—prostate cancer	3.76e-05	0.000376	CcSEcCtD
Verapamil—Dermatitis—Mitoxantrone—prostate cancer	3.76e-05	0.000375	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.76e-05	0.000375	CcSEcCtD
Verapamil—Headache—Mitoxantrone—prostate cancer	3.74e-05	0.000373	CcSEcCtD
Verapamil—Hypotension—Capecitabine—prostate cancer	3.73e-05	0.000372	CcSEcCtD
Verapamil—Insomnia—Docetaxel—prostate cancer	3.73e-05	0.000372	CcSEcCtD
Verapamil—Myalgia—Prednisone—prostate cancer	3.71e-05	0.00037	CcSEcCtD
Verapamil—Arthralgia—Prednisone—prostate cancer	3.71e-05	0.00037	CcSEcCtD
Verapamil—Paraesthesia—Docetaxel—prostate cancer	3.71e-05	0.00037	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—prostate cancer	3.7e-05	0.00037	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—prostate cancer	3.69e-05	0.000368	CcSEcCtD
Verapamil—Dyspnoea—Docetaxel—prostate cancer	3.68e-05	0.000367	CcSEcCtD
Verapamil—Somnolence—Docetaxel—prostate cancer	3.67e-05	0.000366	CcSEcCtD
Verapamil—Discomfort—Prednisone—prostate cancer	3.67e-05	0.000366	CcSEcCtD
Verapamil—Hypersensitivity—Etoposide—prostate cancer	3.66e-05	0.000365	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—prostate cancer	3.65e-05	0.000364	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.64e-05	0.000363	CcSEcCtD
Verapamil—Flushing—Epirubicin—prostate cancer	3.64e-05	0.000363	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—prostate cancer	3.63e-05	0.000363	CcSEcCtD
Verapamil—Dyspepsia—Docetaxel—prostate cancer	3.63e-05	0.000362	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—prostate cancer	3.63e-05	0.000362	CcSEcCtD
Verapamil—Insomnia—Capecitabine—prostate cancer	3.61e-05	0.000361	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—prostate cancer	3.61e-05	0.00036	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—prostate cancer	3.6e-05	0.000359	CcSEcCtD
Verapamil—Paraesthesia—Capecitabine—prostate cancer	3.59e-05	0.000358	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—prostate cancer	3.57e-05	0.000356	CcSEcCtD
Verapamil—Asthenia—Etoposide—prostate cancer	3.56e-05	0.000355	CcSEcCtD
Verapamil—Dyspnoea—Capecitabine—prostate cancer	3.56e-05	0.000355	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisone—prostate cancer	3.56e-05	0.000355	CcSEcCtD
Verapamil—Oedema—Prednisone—prostate cancer	3.56e-05	0.000355	CcSEcCtD
Verapamil—Fatigue—Docetaxel—prostate cancer	3.56e-05	0.000355	CcSEcCtD
Verapamil—Nausea—Mitoxantrone—prostate cancer	3.55e-05	0.000354	CcSEcCtD
Verapamil—Infection—Prednisone—prostate cancer	3.54e-05	0.000353	CcSEcCtD
Verapamil—Constipation—Docetaxel—prostate cancer	3.53e-05	0.000352	CcSEcCtD
Verapamil—Pain—Docetaxel—prostate cancer	3.53e-05	0.000352	CcSEcCtD
Verapamil—Dyspepsia—Capecitabine—prostate cancer	3.52e-05	0.000351	CcSEcCtD
Verapamil—Pruritus—Etoposide—prostate cancer	3.51e-05	0.000351	CcSEcCtD
Verapamil—Shock—Prednisone—prostate cancer	3.5e-05	0.000349	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—prostate cancer	3.49e-05	0.000349	CcSEcCtD
Verapamil—Tachycardia—Prednisone—prostate cancer	3.47e-05	0.000347	CcSEcCtD
Verapamil—Alopecia—Epirubicin—prostate cancer	3.46e-05	0.000345	CcSEcCtD
Verapamil—Fatigue—Capecitabine—prostate cancer	3.44e-05	0.000344	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisone—prostate cancer	3.44e-05	0.000343	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—prostate cancer	3.43e-05	0.000342	CcSEcCtD
Verapamil—Constipation—Capecitabine—prostate cancer	3.42e-05	0.000341	CcSEcCtD
Verapamil—Pain—Capecitabine—prostate cancer	3.42e-05	0.000341	CcSEcCtD
Verapamil—Feeling abnormal—Docetaxel—prostate cancer	3.4e-05	0.000339	CcSEcCtD
Verapamil—Diarrhoea—Etoposide—prostate cancer	3.4e-05	0.000339	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—prostate cancer	3.38e-05	0.000337	CcSEcCtD
Verapamil—Flushing—Doxorubicin—prostate cancer	3.36e-05	0.000336	CcSEcCtD
Verapamil—Feeling abnormal—Capecitabine—prostate cancer	3.29e-05	0.000328	CcSEcCtD
Verapamil—Dizziness—Etoposide—prostate cancer	3.28e-05	0.000328	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—prostate cancer	3.28e-05	0.000327	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Prednisone—prostate cancer	3.24e-05	0.000324	CcSEcCtD
Verapamil—Insomnia—Prednisone—prostate cancer	3.22e-05	0.000321	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—prostate cancer	3.21e-05	0.000321	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—prostate cancer	3.2e-05	0.00032	CcSEcCtD
Verapamil—Paraesthesia—Prednisone—prostate cancer	3.2e-05	0.000319	CcSEcCtD
Verapamil—Urticaria—Capecitabine—prostate cancer	3.17e-05	0.000317	CcSEcCtD
Verapamil—Vomiting—Etoposide—prostate cancer	3.16e-05	0.000315	CcSEcCtD
Verapamil—Agitation—Epirubicin—prostate cancer	3.13e-05	0.000313	CcSEcCtD
Verapamil—Dyspepsia—Prednisone—prostate cancer	3.13e-05	0.000313	CcSEcCtD
Verapamil—Rash—Etoposide—prostate cancer	3.13e-05	0.000312	CcSEcCtD
Verapamil—Dermatitis—Etoposide—prostate cancer	3.13e-05	0.000312	CcSEcCtD
Verapamil—Headache—Etoposide—prostate cancer	3.11e-05	0.00031	CcSEcCtD
Verapamil—Fatigue—Prednisone—prostate cancer	3.07e-05	0.000306	CcSEcCtD
Verapamil—Vertigo—Epirubicin—prostate cancer	3.06e-05	0.000306	CcSEcCtD
Verapamil—Syncope—Epirubicin—prostate cancer	3.06e-05	0.000305	CcSEcCtD
Verapamil—Constipation—Prednisone—prostate cancer	3.04e-05	0.000304	CcSEcCtD
Verapamil—Hypersensitivity—Docetaxel—prostate cancer	3.04e-05	0.000303	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—prostate cancer	3.03e-05	0.000303	CcSEcCtD
Verapamil—Palpitations—Epirubicin—prostate cancer	3.01e-05	0.000301	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—prostate cancer	3e-05	0.000299	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—prostate cancer	2.97e-05	0.000297	CcSEcCtD
Verapamil—Asthenia—Docetaxel—prostate cancer	2.96e-05	0.000295	CcSEcCtD
Verapamil—Convulsion—Epirubicin—prostate cancer	2.96e-05	0.000295	CcSEcCtD
Verapamil—Nausea—Etoposide—prostate cancer	2.95e-05	0.000294	CcSEcCtD
Verapamil—Hypertension—Epirubicin—prostate cancer	2.94e-05	0.000294	CcSEcCtD
Verapamil—Hypersensitivity—Capecitabine—prostate cancer	2.94e-05	0.000294	CcSEcCtD
Verapamil—Feeling abnormal—Prednisone—prostate cancer	2.93e-05	0.000293	CcSEcCtD
Verapamil—Pruritus—Docetaxel—prostate cancer	2.92e-05	0.000291	CcSEcCtD
Verapamil—Chest pain—Epirubicin—prostate cancer	2.9e-05	0.00029	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—prostate cancer	2.9e-05	0.00029	CcSEcCtD
Verapamil—Myalgia—Epirubicin—prostate cancer	2.9e-05	0.00029	CcSEcCtD
Verapamil—Agitation—Doxorubicin—prostate cancer	2.9e-05	0.000289	CcSEcCtD
Verapamil—Discomfort—Epirubicin—prostate cancer	2.87e-05	0.000286	CcSEcCtD
Verapamil—Asthenia—Capecitabine—prostate cancer	2.87e-05	0.000286	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—prostate cancer	2.84e-05	0.000283	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—prostate cancer	2.84e-05	0.000283	CcSEcCtD
Verapamil—Syncope—Doxorubicin—prostate cancer	2.83e-05	0.000282	CcSEcCtD
Verapamil—Urticaria—Prednisone—prostate cancer	2.83e-05	0.000282	CcSEcCtD
Verapamil—Pruritus—Capecitabine—prostate cancer	2.83e-05	0.000282	CcSEcCtD
Verapamil—Diarrhoea—Docetaxel—prostate cancer	2.82e-05	0.000282	CcSEcCtD
Verapamil—Confusional state—Epirubicin—prostate cancer	2.81e-05	0.00028	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—prostate cancer	2.79e-05	0.000278	CcSEcCtD
Verapamil—Oedema—Epirubicin—prostate cancer	2.78e-05	0.000278	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—prostate cancer	2.78e-05	0.000278	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—prostate cancer	2.77e-05	0.000277	CcSEcCtD
Verapamil—Infection—Epirubicin—prostate cancer	2.77e-05	0.000276	CcSEcCtD
Verapamil—Shock—Epirubicin—prostate cancer	2.74e-05	0.000273	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—prostate cancer	2.73e-05	0.000273	CcSEcCtD
Verapamil—Diarrhoea—Capecitabine—prostate cancer	2.73e-05	0.000273	CcSEcCtD
Verapamil—Dizziness—Docetaxel—prostate cancer	2.73e-05	0.000272	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—prostate cancer	2.72e-05	0.000272	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—prostate cancer	2.72e-05	0.000271	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—prostate cancer	2.69e-05	0.000268	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—prostate cancer	2.69e-05	0.000268	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—prostate cancer	2.69e-05	0.000268	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—prostate cancer	2.69e-05	0.000268	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—prostate cancer	2.65e-05	0.000265	CcSEcCtD
Verapamil—Dizziness—Capecitabine—prostate cancer	2.64e-05	0.000264	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—prostate cancer	2.63e-05	0.000262	CcSEcCtD
Verapamil—Vomiting—Docetaxel—prostate cancer	2.62e-05	0.000262	CcSEcCtD
Verapamil—Hypersensitivity—Prednisone—prostate cancer	2.62e-05	0.000262	CcSEcCtD
Verapamil—Rash—Docetaxel—prostate cancer	2.6e-05	0.00026	CcSEcCtD
Verapamil—Hypotension—Epirubicin—prostate cancer	2.6e-05	0.00026	CcSEcCtD
Verapamil—Dermatitis—Docetaxel—prostate cancer	2.6e-05	0.000259	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—prostate cancer	2.6e-05	0.000259	CcSEcCtD
Verapamil—Headache—Docetaxel—prostate cancer	2.59e-05	0.000258	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—prostate cancer	2.58e-05	0.000257	CcSEcCtD
Verapamil—Oedema—Doxorubicin—prostate cancer	2.58e-05	0.000257	CcSEcCtD
Verapamil—Infection—Doxorubicin—prostate cancer	2.56e-05	0.000255	CcSEcCtD
Verapamil—Asthenia—Prednisone—prostate cancer	2.55e-05	0.000255	CcSEcCtD
Verapamil—Vomiting—Capecitabine—prostate cancer	2.54e-05	0.000253	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.54e-05	0.000253	CcSEcCtD
Verapamil—Shock—Doxorubicin—prostate cancer	2.53e-05	0.000253	CcSEcCtD
Verapamil—Rash—Capecitabine—prostate cancer	2.52e-05	0.000251	CcSEcCtD
Verapamil—Pruritus—Prednisone—prostate cancer	2.52e-05	0.000251	CcSEcCtD
Verapamil—Insomnia—Epirubicin—prostate cancer	2.52e-05	0.000251	CcSEcCtD
Verapamil—Dermatitis—Capecitabine—prostate cancer	2.52e-05	0.000251	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—prostate cancer	2.51e-05	0.000251	CcSEcCtD
Verapamil—Headache—Capecitabine—prostate cancer	2.5e-05	0.00025	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—prostate cancer	2.5e-05	0.000249	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—prostate cancer	2.49e-05	0.000248	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—prostate cancer	2.48e-05	0.000248	CcSEcCtD
Verapamil—Somnolence—Epirubicin—prostate cancer	2.47e-05	0.000247	CcSEcCtD
Verapamil—Nausea—Docetaxel—prostate cancer	2.45e-05	0.000245	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—prostate cancer	2.45e-05	0.000244	CcSEcCtD
Verapamil—Diarrhoea—Prednisone—prostate cancer	2.44e-05	0.000243	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—prostate cancer	2.41e-05	0.00024	CcSEcCtD
Verapamil—Fatigue—Epirubicin—prostate cancer	2.4e-05	0.000239	CcSEcCtD
Verapamil—Constipation—Epirubicin—prostate cancer	2.38e-05	0.000237	CcSEcCtD
Verapamil—Pain—Epirubicin—prostate cancer	2.38e-05	0.000237	CcSEcCtD
Verapamil—Nausea—Capecitabine—prostate cancer	2.37e-05	0.000237	CcSEcCtD
Verapamil—Dizziness—Prednisone—prostate cancer	2.35e-05	0.000235	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.35e-05	0.000234	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—prostate cancer	2.33e-05	0.000232	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—prostate cancer	2.31e-05	0.000231	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—prostate cancer	2.3e-05	0.000229	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—prostate cancer	2.29e-05	0.000229	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—prostate cancer	2.29e-05	0.000228	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—prostate cancer	2.27e-05	0.000226	CcSEcCtD
Verapamil—Vomiting—Prednisone—prostate cancer	2.26e-05	0.000226	CcSEcCtD
Verapamil—Rash—Prednisone—prostate cancer	2.24e-05	0.000224	CcSEcCtD
Verapamil—Dermatitis—Prednisone—prostate cancer	2.24e-05	0.000224	CcSEcCtD
Verapamil—Headache—Prednisone—prostate cancer	2.23e-05	0.000222	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—prostate cancer	2.22e-05	0.000222	CcSEcCtD
Verapamil—Urticaria—Epirubicin—prostate cancer	2.21e-05	0.000221	CcSEcCtD
Verapamil—Pain—Doxorubicin—prostate cancer	2.2e-05	0.00022	CcSEcCtD
Verapamil—Constipation—Doxorubicin—prostate cancer	2.2e-05	0.00022	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—prostate cancer	2.12e-05	0.000212	CcSEcCtD
Verapamil—Nausea—Prednisone—prostate cancer	2.11e-05	0.000211	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—prostate cancer	2.05e-05	0.000205	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—prostate cancer	2.05e-05	0.000204	CcSEcCtD
Verapamil—Asthenia—Epirubicin—prostate cancer	2e-05	0.000199	CcSEcCtD
Verapamil—Pruritus—Epirubicin—prostate cancer	1.97e-05	0.000196	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—prostate cancer	1.9e-05	0.00019	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—prostate cancer	1.9e-05	0.000189	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—prostate cancer	1.85e-05	0.000184	CcSEcCtD
Verapamil—Dizziness—Epirubicin—prostate cancer	1.84e-05	0.000184	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—prostate cancer	1.82e-05	0.000182	CcSEcCtD
Verapamil—Vomiting—Epirubicin—prostate cancer	1.77e-05	0.000177	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—prostate cancer	1.76e-05	0.000176	CcSEcCtD
Verapamil—Rash—Epirubicin—prostate cancer	1.76e-05	0.000175	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—prostate cancer	1.75e-05	0.000175	CcSEcCtD
Verapamil—Headache—Epirubicin—prostate cancer	1.74e-05	0.000174	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—prostate cancer	1.7e-05	0.00017	CcSEcCtD
Verapamil—Nausea—Epirubicin—prostate cancer	1.65e-05	0.000165	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—prostate cancer	1.64e-05	0.000163	CcSEcCtD
Verapamil—Rash—Doxorubicin—prostate cancer	1.62e-05	0.000162	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—prostate cancer	1.62e-05	0.000162	CcSEcCtD
Verapamil—Headache—Doxorubicin—prostate cancer	1.61e-05	0.000161	CcSEcCtD
Verapamil—Nausea—Doxorubicin—prostate cancer	1.53e-05	0.000153	CcSEcCtD
Verapamil—ABCB1—Metabolism—ITPR1—prostate cancer	7.45e-07	7.18e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—RXRA—prostate cancer	7.44e-07	7.17e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—RXRA—prostate cancer	7.38e-07	7.11e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2E1—prostate cancer	7.33e-07	7.06e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CB—prostate cancer	7.32e-07	7.06e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NOS3—prostate cancer	7.32e-07	7.05e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NCOA3—prostate cancer	7.28e-07	7.01e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CB—prostate cancer	7.26e-07	6.99e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—prostate cancer	7.26e-07	6.99e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NQO1—prostate cancer	7.25e-07	6.98e-06	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—prostate cancer	7.23e-07	6.96e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TYMS—prostate cancer	7.21e-07	6.95e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—prostate cancer	7.19e-07	6.93e-06	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTEN—prostate cancer	7.19e-07	6.93e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.18e-07	6.91e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—COMT—prostate cancer	7.17e-07	6.91e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TH—prostate cancer	7.14e-07	6.88e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—prostate cancer	7.14e-07	6.88e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTP1—prostate cancer	7.14e-07	6.87e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTM1—prostate cancer	7.13e-07	6.87e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—prostate cancer	7.12e-07	6.86e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—COMT—prostate cancer	7.11e-07	6.85e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.1e-07	6.84e-06	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—prostate cancer	7.1e-07	6.83e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTP1—prostate cancer	7.08e-07	6.82e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP3A4—prostate cancer	7.07e-07	6.81e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—prostate cancer	7.06e-07	6.8e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TYMS—prostate cancer	7.04e-07	6.78e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.03e-07	6.77e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ITPR1—prostate cancer	7.02e-07	6.76e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CG—prostate cancer	7.01e-07	6.75e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—LPL—prostate cancer	7e-07	6.74e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—prostate cancer	6.98e-07	6.72e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ITPR1—prostate cancer	6.96e-07	6.71e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTM1—prostate cancer	6.96e-07	6.7e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1B1—prostate cancer	6.95e-07	6.69e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HPGDS—prostate cancer	6.94e-07	6.69e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARA—prostate cancer	6.93e-07	6.67e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.9e-07	6.64e-06	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—EP300—prostate cancer	6.86e-07	6.61e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CG—prostate cancer	6.85e-07	6.6e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.85e-07	6.59e-06	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTEN—prostate cancer	6.84e-07	6.58e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—LPL—prostate cancer	6.83e-07	6.58e-06	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—prostate cancer	6.77e-07	6.52e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1A1—prostate cancer	6.76e-07	6.51e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CB—prostate cancer	6.76e-07	6.51e-06	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—prostate cancer	6.75e-07	6.51e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTT1—prostate cancer	6.73e-07	6.48e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ACHE—prostate cancer	6.73e-07	6.48e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GGT1—prostate cancer	6.73e-07	6.48e-06	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—prostate cancer	6.72e-07	6.47e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ERCC2—prostate cancer	6.7e-07	6.46e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—prostate cancer	6.69e-07	6.45e-06	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—prostate cancer	6.66e-07	6.41e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.65e-07	6.41e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TYMS—prostate cancer	6.64e-07	6.39e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—INS—prostate cancer	6.63e-07	6.39e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NCOA1—prostate cancer	6.63e-07	6.39e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1A1—prostate cancer	6.6e-07	6.36e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—prostate cancer	6.6e-07	6.35e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TYMS—prostate cancer	6.58e-07	6.34e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTM1—prostate cancer	6.56e-07	6.32e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ERCC2—prostate cancer	6.54e-07	6.3e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP19A1—prostate cancer	6.53e-07	6.29e-06	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—EP300—prostate cancer	6.52e-07	6.28e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CAV1—prostate cancer	6.51e-07	6.27e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTM1—prostate cancer	6.5e-07	6.26e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CREBBP—prostate cancer	6.5e-07	6.26e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—INS—prostate cancer	6.48e-07	6.24e-06	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—prostate cancer	6.48e-07	6.24e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.47e-07	6.24e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PRKACB—prostate cancer	6.44e-07	6.2e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—LPL—prostate cancer	6.44e-07	6.2e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—LPL—prostate cancer	6.38e-07	6.15e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.37e-07	6.14e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CREBBP—prostate cancer	6.35e-07	6.12e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTEN—prostate cancer	6.33e-07	6.1e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—RXRA—prostate cancer	6.31e-07	6.07e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—prostate cancer	6.3e-07	6.07e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTEN—prostate cancer	6.27e-07	6.04e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.22e-07	5.99e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1A1—prostate cancer	6.22e-07	5.99e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARA—prostate cancer	6.18e-07	5.96e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ERCC2—prostate cancer	6.17e-07	5.94e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.16e-07	5.94e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CD—prostate cancer	6.16e-07	5.93e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—prostate cancer	6.15e-07	5.92e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.13e-07	5.91e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ERCC2—prostate cancer	6.11e-07	5.89e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—COMT—prostate cancer	6.08e-07	5.85e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NCOA2—prostate cancer	6.07e-07	5.85e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—prostate cancer	6.06e-07	5.84e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTP1—prostate cancer	6.05e-07	5.82e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—EP300—prostate cancer	6.04e-07	5.81e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARA—prostate cancer	6.03e-07	5.81e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CD—prostate cancer	6.02e-07	5.8e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—EP300—prostate cancer	5.98e-07	5.76e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ITPR1—prostate cancer	5.95e-07	5.73e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CG—prostate cancer	5.93e-07	5.71e-06	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—prostate cancer	5.9e-07	5.69e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.85e-07	5.63e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTEN—prostate cancer	5.84e-07	5.62e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NOS3—prostate cancer	5.82e-07	5.6e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CAV1—prostate cancer	5.81e-07	5.6e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—prostate cancer	5.8e-07	5.58e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.79e-07	5.58e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—prostate cancer	5.75e-07	5.54e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARA—prostate cancer	5.69e-07	5.48e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NOS3—prostate cancer	5.69e-07	5.48e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CAV1—prostate cancer	5.67e-07	5.47e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.66e-07	5.45e-06	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—prostate cancer	5.64e-07	5.43e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARA—prostate cancer	5.64e-07	5.43e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TYMS—prostate cancer	5.62e-07	5.41e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—INS—prostate cancer	5.62e-07	5.41e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NQO1—prostate cancer	5.59e-07	5.39e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—EP300—prostate cancer	5.57e-07	5.36e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTM1—prostate cancer	5.56e-07	5.35e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.55e-07	5.35e-06	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—prostate cancer	5.52e-07	5.32e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TH—prostate cancer	5.51e-07	5.31e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CREBBP—prostate cancer	5.5e-07	5.3e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LPL—prostate cancer	5.45e-07	5.25e-06	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—prostate cancer	5.44e-07	5.24e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CB—prostate cancer	5.37e-07	5.17e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—prostate cancer	5.37e-07	5.17e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.36e-07	5.17e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CAV1—prostate cancer	5.35e-07	5.15e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—prostate cancer	5.32e-07	5.12e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CAV1—prostate cancer	5.3e-07	5.11e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CG—prostate cancer	5.3e-07	5.1e-06	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—prostate cancer	5.29e-07	5.1e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.27e-07	5.07e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CB—prostate cancer	5.25e-07	5.06e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ERCC2—prostate cancer	5.22e-07	5.03e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CD—prostate cancer	5.22e-07	5.02e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—prostate cancer	5.2e-07	5.01e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GGT1—prostate cancer	5.2e-07	5e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CG—prostate cancer	5.17e-07	4.98e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NCOA1—prostate cancer	5.12e-07	4.93e-06	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—prostate cancer	5.07e-07	4.89e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.06e-07	4.88e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.04e-07	4.86e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—INS—prostate cancer	5.01e-07	4.83e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—prostate cancer	4.95e-07	4.77e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NOS3—prostate cancer	4.92e-07	4.74e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—prostate cancer	4.91e-07	4.73e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CREBBP—prostate cancer	4.91e-07	4.73e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—INS—prostate cancer	4.89e-07	4.71e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CG—prostate cancer	4.87e-07	4.69e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—RXRA—prostate cancer	4.87e-07	4.69e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CG—prostate cancer	4.83e-07	4.65e-06	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—prostate cancer	4.82e-07	4.64e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARA—prostate cancer	4.82e-07	4.64e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CREBBP—prostate cancer	4.79e-07	4.62e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—COMT—prostate cancer	4.69e-07	4.52e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTP1—prostate cancer	4.67e-07	4.49e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CD—prostate cancer	4.65e-07	4.48e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTEN—prostate cancer	4.64e-07	4.47e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—INS—prostate cancer	4.61e-07	4.44e-06	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—prostate cancer	4.61e-07	4.44e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ITPR1—prostate cancer	4.59e-07	4.42e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—INS—prostate cancer	4.57e-07	4.4e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CB—prostate cancer	4.55e-07	4.38e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CD—prostate cancer	4.54e-07	4.38e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTEN—prostate cancer	4.53e-07	4.37e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CAV1—prostate cancer	4.53e-07	4.36e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CREBBP—prostate cancer	4.52e-07	4.35e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—prostate cancer	4.5e-07	4.34e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CREBBP—prostate cancer	4.48e-07	4.31e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—prostate cancer	4.47e-07	4.3e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—prostate cancer	4.43e-07	4.26e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—EP300—prostate cancer	4.42e-07	4.26e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NOS3—prostate cancer	4.4e-07	4.23e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TYMS—prostate cancer	4.34e-07	4.18e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.33e-07	4.17e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—EP300—prostate cancer	4.32e-07	4.17e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NOS3—prostate cancer	4.29e-07	4.13e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTM1—prostate cancer	4.29e-07	4.13e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CD—prostate cancer	4.28e-07	4.12e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.24e-07	4.09e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LPL—prostate cancer	4.21e-07	4.05e-06	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—prostate cancer	4.15e-07	3.99e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CG—prostate cancer	4.13e-07	3.97e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—prostate cancer	4.12e-07	3.97e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.07e-07	3.92e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CB—prostate cancer	4.06e-07	3.91e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NOS3—prostate cancer	4.04e-07	3.89e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ERCC2—prostate cancer	4.03e-07	3.88e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—prostate cancer	4.02e-07	3.87e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NOS3—prostate cancer	4.01e-07	3.86e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CB—prostate cancer	3.96e-07	3.81e-06	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—prostate cancer	3.94e-07	3.79e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTEN—prostate cancer	3.93e-07	3.78e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—prostate cancer	3.92e-07	3.78e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—INS—prostate cancer	3.91e-07	3.76e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CREBBP—prostate cancer	3.83e-07	3.68e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—prostate cancer	3.79e-07	3.65e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—EP300—prostate cancer	3.75e-07	3.61e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CB—prostate cancer	3.73e-07	3.59e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARA—prostate cancer	3.72e-07	3.58e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.7e-07	3.56e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—prostate cancer	3.7e-07	3.56e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—prostate cancer	3.67e-07	3.53e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—prostate cancer	3.65e-07	3.51e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.63e-07	3.49e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—prostate cancer	3.62e-07	3.48e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTEN—prostate cancer	3.51e-07	3.38e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CAV1—prostate cancer	3.5e-07	3.37e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NOS3—prostate cancer	3.42e-07	3.3e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTEN—prostate cancer	3.42e-07	3.3e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—prostate cancer	3.36e-07	3.24e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—EP300—prostate cancer	3.34e-07	3.22e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—prostate cancer	3.27e-07	3.15e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—EP300—prostate cancer	3.26e-07	3.14e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTEN—prostate cancer	3.22e-07	3.11e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.2e-07	3.08e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTEN—prostate cancer	3.2e-07	3.08e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.18e-07	3.07e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.16e-07	3.05e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—prostate cancer	3.13e-07	3.02e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—EP300—prostate cancer	3.08e-07	2.96e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—EP300—prostate cancer	3.05e-07	2.94e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—INS—prostate cancer	3.01e-07	2.9e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CREBBP—prostate cancer	2.95e-07	2.84e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.8e-07	2.7e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.77e-07	2.67e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTEN—prostate cancer	2.73e-07	2.63e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—prostate cancer	2.67e-07	2.58e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NOS3—prostate cancer	2.64e-07	2.55e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—prostate cancer	2.61e-07	2.52e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—EP300—prostate cancer	2.61e-07	2.51e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.47e-07	2.38e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.44e-07	2.35e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—prostate cancer	2.42e-07	2.33e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—prostate cancer	2.41e-07	2.33e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.27e-07	2.19e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—prostate cancer	2.26e-07	2.18e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.26e-07	2.17e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTEN—prostate cancer	2.11e-07	2.03e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—prostate cancer	2.02e-07	1.95e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—EP300—prostate cancer	2.01e-07	1.94e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—prostate cancer	1.97e-07	1.9e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.93e-07	1.86e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—prostate cancer	1.86e-07	1.79e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—prostate cancer	1.84e-07	1.77e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—prostate cancer	1.57e-07	1.52e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.49e-07	1.43e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—prostate cancer	1.22e-07	1.17e-06	CbGpPWpGaD
